ISPOR 2014 - 2015 President Elect

Adrian Towse, MA, MPhilOffice of Health Economics

London, UK

Incoming Presidential Address

1. Continuing to globalise2. Responding to growing payer demand for

evidence of value 3. Continuing to raise HEOR scientific

standards 4. Supporting the next generation of

researchers.

Challenges facing ISPOR

• Globalisation of ISPOR has to be linked to an understanding of decision making in emerging country health systems

• There is growing desire in low and middle income countries to achieve universal health coverage (UHC) for their populations

• Using HTA to support priority setting as part of UHC will be important

• A key question in HTA will be the potential transferability of evidence (its ‘public good’ characteristics)

• But so will creating incentives in health care systems to achieve better outcomes, and measuring performance

In other words, diverse health systems have different challenges. ISPOR has to anticipate and respond to these needs

The first challenge: globalisation

• Outcomes research is ‘the scientific discipline that evaluates the effect of health care interventions on patient related if not patient specific, clinical, humanistic and economic outcomes’

• Health care intervention: ‘a program, policy, measure, or activitydesigned to have an impact on an illness or disease in an individual or a population’

• Health care technology (for HTA) consists of:– Drugs, biologics, devices, procedures– Support systems, organisational, delivery and managerial systems

(e.g. disease management programme, health care payment system)

Source: ISPOR Book of Terms

Break out of narrow perspectives

Beijing, China6-9 September 2014

Early Registration Deadline:

22 July 2014

ISPOR Meetings

Amsterdam,

The Netherlands8-12 November 2014

Abstract Submission Deadline:

24 June 2014

MEETINGSISPOR Meetings

VIH Co-editors-in–chief

Publications strength

Michael Drummond Dan Mullins

VIHRI Co-editors-in–chief

Publications strength

Bong-Min Yang Federico Augustovski Dan Greenberg

VIH Impact Factor projected to be up

30%

Upcoming Webinars

Performance-Based Risk-Sharing Arrangements (July)

Budget Impact Analysis II (September)

Assessing the Evidence - Modeling Studies (November)

Assessing the Evidence - Observational Studies (October)

Assessing the Evidence - Indirect Treatment Comparison Studies (December)

ISPOR Task Force Reportsin Development

Good Practices on:

Cost-Effectiveness Analysis Alongside Clinical TrialsMulti-Criteria Decision Analysis for Health Care DecisionCollecting and Analyzing Utility Data for Economic ModelsModeling Health State Utility Values - Mapping

2014-2016 Directors

President Elect

2014-2015 ISPOR Board of Directors

2013-2015 Directors

Past President Treasurer

2014-2015 ISPOR Board of Directors

Providing efficient and effective health care is a

global challenge

ISPOR is a global organisation that exists to help meet

this challenge

Diverse health systems have different challenges. ISPOR has to anticipate and respond to these needs: must break out

of narrow perspectives

Thank You!The full text of Professor Towse’s remarks is available on the OHE blog, OHE News.